EICHORCondition: Liver Cancer, Adult · Metastatic Liver Cancers · HCC - Hepatocellular Carcinoma · Sponsor: Shen Lin
This is the first-in-human trial of MTS105 (mRNA-LNP). The goal of this clinical trial is to evaluate the safety, tolerability of intravenous injection of MTS105 in advanced hepatocellular carcinoma.
This description comes directly from the study's public registry record.
Lin Professor, M.D · 010 88196561 · Linshenpku@163.com
Always discuss trial participation with your own doctor first.
| Peking University Cancer Hospital | Beijing, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06689540